March 2, 2016
Unum Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
CAMBRIDGE, MA, March 2, 2016 – Unum Therapeutics, a company developing a universal cellular immunotherapy to treat multiple cancers, today announced that President and Chief Executive Officer Chuck Wilson will present at the Cowen and Company’s 36th Annual Health Care Conference on Monday, March 7, 2016 at 8:30 a.m. EST at the Boston Marriott Copley Place.
Unum uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. The Company’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is in Phase 1 clinical testing to assess its safety and efficacy. The company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com.
Sam Brown Inc.